Skip to main content
Erschienen in: BMC Medicine 1/2014

Open Access 01.12.2014 | Question and Answer

Video Q & A: The impact of stress. An interview with George Chrousos

verfasst von: George Chrousos

Erschienen in: BMC Medicine | Ausgabe 1/2014

Abstract

In this video Q & A, we talk to George Chrousos about stress and its impact on chronic non-communicable disorders (NCDs) and early life development. Professor Chrousos also discusses the effects of psychological and economical stressors on health, and suggests ways in which we can learn to cope with stress.
Begleitmaterial
An interview with George Chrousos: (MP4 66 MB)
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1741-7015-12-102) contains supplementary material, which is available to authorized users.

Competing interests

GC has no competing interests to declare.

An interview with George Chrousos

Introduction

George Chrousos is currently the Chairman of the First Department of Pediatrics at the University of Athens School of Medicine, Greece and the former Chief of the Pediatric and Reproductive Endocrinology Branch of the National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), USA. He also holds the UNESCO Chair on Adolescent Health Care at the University of Athens and held the 2011 John Kluge Distinguished Chair in Technology and Society at the Library of Congress, Washington, D.C. His research has focused on the glucocorticoid signaling system, diseases of the hypothalamic-pituitary-adrenal (HPA) axis and on the physiological and molecular mechanisms of stress. His research contributions span a wide range of medical disciplines, and his early ground-breaking research first described the syndrome Primary Generalized Glucocorticoid Resistance (more recently termed “Chrousos syndrome”), which is a rare genetic or sporadic condition characterized by glucocorticoid insensitivity. Professor Chrousos’s recent research includes the management of stress during pregnancy and the genetic variation of the HPA in relation to the stress response in asthmatic children.

Edited transcript

(1) How would you differentiate between stress and stressors?

First, we need to discuss homeostasis, which is basically the balance or the equilibrium that human beings or living organisms need to maintain. Stressors are the stimuli that disturb or threaten homeostasis. The adaptive response is what the organism is doing to antagonize the stressor, and stress is the state of threatened homeostasis, so when an organism is under stress then there is a stressor that disturbs that organism’s homoeostasis.

(2) What biological systems are associated with the stress response?

During the stress response the entire organism participates; however, there is a system which is called the ‘stress system’ that is activated once the stressor exceeds a certain threshold. This system consists of brain and peripheral components. In the brain the paraventricular nucleus in the hypothalamus contains neurons that secrete corticotropin- releasing hormone, which then circulates in the hypophysial portal system to the pituitary where it stimulates the secretion of adrenocorticotropic hormone (ACTH). In the systemic circulation ACTH stimulates the secretion of cortisol from the adrenal cortex. In addition, there is another center in the brain called the locus caeruleus/norepinephrine system, which is in the brainstem and is the center of the arousal and autonomic nervous systems which consist of the adrenomedullary and the systemic sympathetic system components.

(3) What disorders are affected by the stress system?

The stress system when activated can precipitate acute and chronic disorders. For acute disorders, for example, a stressor can precipitate an asthma attack, a hypertensive episode or a psychotic episode. For chronic conditions, this is more serious, as chronic stress can result in several chronic non-communicable diseases, including obesity, metabolic syndrome, diabetes mellitus type 2, hypertension, depression and anxiety.

(4) What is the role of genetic vulnerability to stressors in our environment?

Our vulnerability to stressors depends to a great extent on our genes (polygenic) and also on our epigenetics, which express the effect of our environment on our genetic material.

(5) What are the long-term effects of stress in prenatal and early life?

Prenatal and early life, (especially the first five years of life), are extremely vulnerable periods and that is why they are called critical or critically vulnerable periods. If there is stress during this time the stress hormones leave behind an epigenetic imprint, which accompanies the child for the rest of his or her life into adulthood and old age.

(6) How do psychological and economic factors affect stress?

In modern society most of the stress we are exposed to is social and, in a sense, to a large extent, anthropogenic. The economy is part of social life, so if someone does not have the economic means to live a normal life and needs to scrounge around for resources, then this causes stress which is damaging to the organism. There is no distinction between financial, social and peer-generated stress and they are all damaging through the same pathophysiologic mechanisms.

(7) What are the proven methods that prevent stress?

Two things need to be done when faced with stress; first, one has to eliminate the stressor or get away from it, which is a smart move; for example, if someone is in a stressful job then that person needs to consider changing jobs. However, if this cannot be done, then that individual needs to learn to cope with stress and there are many ways to do this. These include leading a healthy life, which involves (1) eating a good diet and high quality nutrition; (2) performing exercise regularly; (3) having good timing of daily activities, for example, waking up and having breakfast should be at approximately the same time of the day and (4) sleeping well. Unfortunately, in the last 30 years we sleep on average two hours less than the duration of sleep of people in the 1970s and this is stressful for the body as it alters metabolism. It is very well known now that the lack of sleep ultimately damages the blood vessels and leads to chronic stress in an individual.

(8) What are the future directions of this important topic of research?

First, the message needs to be promoted. Second, there is a requirement for social and political changes that will guarantee that our children are not exposed to stress but have enriching experiences. Third, society needs to learn how to cope with situations that cannot be avoided. So far it seems that one of the psychiatric and psychological methods that is used quite successfully to cope with chronic social stress is cognitive behavioral therapy.

(9) Where can I find out more?

See references [113].
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​4.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

GC has no competing interests to declare.
Anhänge

Electronic supplementary material

An interview with George Chrousos: (MP4 66 MB)
Literatur
2.
Zurück zum Zitat Chrousos GP, Gold PW: The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA. 1992, 267: 1244-1252. 10.1001/jama.1992.03480090092034.CrossRefPubMed Chrousos GP, Gold PW: The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA. 1992, 267: 1244-1252. 10.1001/jama.1992.03480090092034.CrossRefPubMed
3.
Zurück zum Zitat Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995, 332: 1351-1362. 10.1056/NEJM199505183322008.CrossRefPubMed Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995, 332: 1351-1362. 10.1056/NEJM199505183322008.CrossRefPubMed
4.
Zurück zum Zitat Elenkov IJ, Chrousos GP: Stress hormones, Th1/Th2-patterns, pro/anti- inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab. 1999, 10: 359-368. 10.1016/S1043-2760(99)00188-5.CrossRefPubMed Elenkov IJ, Chrousos GP: Stress hormones, Th1/Th2-patterns, pro/anti- inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab. 1999, 10: 359-368. 10.1016/S1043-2760(99)00188-5.CrossRefPubMed
5.
Zurück zum Zitat Makrigiannakis A, Zoumakis E, Kalantaridou S, Coutifaris C, Coukos G, Rice K, Gravanis A, Chrousos GP: Corticotropin-releasing hormone (CRH) promotes blastocyst implantation and early maternal tolerance. Nat Immunol. 2001, 2: 1018-1024. 10.1038/ni719.CrossRefPubMed Makrigiannakis A, Zoumakis E, Kalantaridou S, Coutifaris C, Coukos G, Rice K, Gravanis A, Chrousos GP: Corticotropin-releasing hormone (CRH) promotes blastocyst implantation and early maternal tolerance. Nat Immunol. 2001, 2: 1018-1024. 10.1038/ni719.CrossRefPubMed
6.
Zurück zum Zitat Pervanidou P, Kolaitis G, Charitaki S, Lazaropoulou C, Papassotiriou I, Hindmarsh P, Bakoula C, Tsiantis J, Chrousos GP: The natural history of neuroendocrine changes in pediatric post-traumatic stress disorder (PTSD) after motor vehicle accidents: progressive divergence of noradrenaline and cortisol concentrations over time. Biol Psychiatry. 2007, 62: 1095-1102. 10.1016/j.biopsych.2007.02.008.CrossRefPubMed Pervanidou P, Kolaitis G, Charitaki S, Lazaropoulou C, Papassotiriou I, Hindmarsh P, Bakoula C, Tsiantis J, Chrousos GP: The natural history of neuroendocrine changes in pediatric post-traumatic stress disorder (PTSD) after motor vehicle accidents: progressive divergence of noradrenaline and cortisol concentrations over time. Biol Psychiatry. 2007, 62: 1095-1102. 10.1016/j.biopsych.2007.02.008.CrossRefPubMed
7.
Zurück zum Zitat Chrousos GP: Stress and disorders of the stress system. Nat Rev Endocrinol. 2009, 5: 374-381. 10.1038/nrendo.2009.106.CrossRefPubMed Chrousos GP: Stress and disorders of the stress system. Nat Rev Endocrinol. 2009, 5: 374-381. 10.1038/nrendo.2009.106.CrossRefPubMed
8.
9.
Zurück zum Zitat Charmandari E, Chrousos GP, Lambrou GI, Pavlaki A, Koide H, Ng SS, Kino T: Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man. PLoS ONE. 2011, 6: e25612-10.1371/journal.pone.0025612.CrossRefPubMedPubMedCentral Charmandari E, Chrousos GP, Lambrou GI, Pavlaki A, Koide H, Ng SS, Kino T: Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man. PLoS ONE. 2011, 6: e25612-10.1371/journal.pone.0025612.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Pervanidou P, Chrousos GP: Posttraumatic stress disorder in children and adolescents: neuroendocrine perspectives. Sci Signal. 2012, 5: pt6.CrossRefPubMed Pervanidou P, Chrousos GP: Posttraumatic stress disorder in children and adolescents: neuroendocrine perspectives. Sci Signal. 2012, 5: pt6.CrossRefPubMed
11.
Zurück zum Zitat Charmandari E, Achermann JC, Carel JC, Soder O, Chrousos GP: Stress response and child health. Sci Signal. 2012, 5: mr1.PubMed Charmandari E, Achermann JC, Carel JC, Soder O, Chrousos GP: Stress response and child health. Sci Signal. 2012, 5: mr1.PubMed
12.
Zurück zum Zitat Kino T, Charmandari E, Chrousos GP: Chapter 29. Disorders of the hypothalamic-pituitary-adrenocortical system. Handbook of Neuroendocrinology. Edited by: Fink G, Pfaff DW, Levine JE. 2012, London, UK: Waltham, MA; San Diego, CA: Academic Press, Elsevier, 639-658.CrossRef Kino T, Charmandari E, Chrousos GP: Chapter 29. Disorders of the hypothalamic-pituitary-adrenocortical system. Handbook of Neuroendocrinology. Edited by: Fink G, Pfaff DW, Levine JE. 2012, London, UK: Waltham, MA; San Diego, CA: Academic Press, Elsevier, 639-658.CrossRef
13.
Zurück zum Zitat Chrousos GP: Stress in early life: a developmental and evolutionary perspective. Z. Hochberg Evo-Devo of Child Growth. 2012, Hoboken, NJ: Wiley-Blackwell Co, 29-40. Chrousos GP: Stress in early life: a developmental and evolutionary perspective. Z. Hochberg Evo-Devo of Child Growth. 2012, Hoboken, NJ: Wiley-Blackwell Co, 29-40.
Metadaten
Titel
Video Q & A: The impact of stress. An interview with George Chrousos
verfasst von
George Chrousos
Publikationsdatum
01.12.2014
Verlag
BioMed Central
Erschienen in
BMC Medicine / Ausgabe 1/2014
Elektronische ISSN: 1741-7015
DOI
https://doi.org/10.1186/1741-7015-12-102

Weitere Artikel der Ausgabe 1/2014

BMC Medicine 1/2014 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Metformin rückt in den Hintergrund

24.04.2024 DGIM 2024 Kongressbericht

Es hat sich über Jahrzehnte klinisch bewährt. Doch wo harte Endpunkte zählen, ist Metformin als alleinige Erstlinientherapie nicht mehr zeitgemäß.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.